跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RECIGARUM 1,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RECIGARUM 1,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
RECIGARUM 1,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Adamed Pharma S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 24, 2025
Approval ID
0fa57e38380bf341
Company
Adamed Pharma S.A.
Type
Standard
Approval Details
Approval Id
0fa57e38380bf341
Drug Cima Aemps Name
RECIGARUM 1,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
25108
Holder Company Name
Adamed Pharma S.A.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/adamed-pharma-s-a
Authorization Date
2025-03-24
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
1,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Adamed Pharma S.A.
Company Detail Path
/organization/adamed-pharma-s-a
Company Information
Pharmaceutical Company Name
Adamed Pharma S.A.
Country Name
Poland
Website
https://www.adamed.com/
Active Ingredients
CITISINICLINA
1,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 24, 2025
Approval ID
0fa57e38380bf341
Type
Standard
Back to CIMA-AEMPS Approvals